The latest health news reveals Medtronic's strategic response to U.S. tariffs, WHO's concerns on West Bank violence, mystery ...

In a welcome move, Medtronic stock saw its Relative Strength Rating improve from 67 to 73 on Tuesday. Please watch the video ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...

Medtronic (NYSE:MDT), which has operations worldwide, is reportedly looking at adjusting its manufacturing footprint amid ...

The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to ...

Medtronic's agnostic approach to global challenges, including tariffs and AI, ensures success and innovation in healthcare ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Dania Daye, MD, PhD Associate Professor of Radiology, Harvard Medical School IR Division Quality Director Co-Director of IR ...

A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...

Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...

The neurovascular market, estimated at $4.2bn in 2024 by GlobalData, is becoming increasingly specialised and competitive.